International Myeloma Foundation

International Myeloma Foundation Let’s face multiple myeloma together. We’re here with support, resources, and community. Improving Lives, Finding the Cure. and worldwide.

Research
The International Myeloma Foundation is dedicated to finding a cure for those living with multiple myeloma. We have a range of initiatives to make this happen. Education
Because "Knowledge Is Power," the IMF brings educational seminars and workshops to communities near you, and provides a library of publications on multiple myeloma care. Support
Since our inception in 1990, the IMF has supported and met in-person with more than 3,000 myeloma patients globally. Advocacy
The IMF’s Advocacy team has educated and empowered thousands of individuals who make a positive impact each year on issues critical to the myeloma community in the U.S.

02/01/2026

This community is the heart of everything we do. Whether you’re living with myeloma, caring for someone you love, advocating, or supporting research, you belong here. We’re showing up for you with education, connection, and real support every step of the way. Find a seminar or workshop near you at events.myeloma.org.

02/01/2026

Do you have more questions about myeloma? We host seminars, workshops, and online webinars throughout the year to help you learn and get support. Visit events.myeloma.org to get connected.

02/01/2026

What’s your go-to comfort food?
Advocate, Support Group Leader, and 14-year myeloma survivor Michael Riotto asked IMF President & CEO Heather Cooper Ortner her favorite food. Her answer: a good piece of dark chocolate. She’ll bring the chocolate if you bring the fries.

01/30/2026

Join a free IMF educational event near you or online at events.myeloma.org for trusted myeloma education, access to experts, and meaningful connection. Let's get connected! Learn more at events.myeloma.org

! Connect with the myeloma community, build your support network, ask the experts your questions, find support in your ...
01/29/2026

! Connect with the myeloma community, build your support network, ask the experts your questions, find support in your community, and more at the FREE IMF Myeloma Community Workshop on June 27! Will we see you there? Save your seat: https://mmsm.link/4qz1zVQ

01/28/2026

Okay… what’s YOUR anthem right now? Drop it in the comments.

Myeloma thriver Oya Gilbert asked IMF President & CEO Heather Cooper Ortner what song keeps her going when life gets hard. Her answer: “Don’t Stop Believin’” by Journey.

Find a seminar or workshop near you: events.myeloma.org

If you are newly diagnosed with multiple myeloma and cannot receive a stem cell transplant, this is important. A treatme...
01/28/2026

If you are newly diagnosed with multiple myeloma and cannot receive a stem cell transplant, this is important. A treatment once limited to transplant-eligible patients is now approved for those who are not.

Until now, Darzalex Faspro combined with VRd was only approved for people newly diagnosed with multiple myeloma who were eligible for a stem cell transplant.

That has now changed.

The FDA has approved Darzalex Faspro in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for adults with newly diagnosed multiple myeloma who are not eligible for a stem cell transplant.

This approval is based on results from the CEPHEUS study, a clinical trial focused on people starting treatment who could not receive a transplant or chose not to have one as their first therapy. The lead investigator of this study, Dr. Saad Usmani, is a member of the International Myeloma Foundation’s Scientific Advisory Board and the International Myeloma Working Group.

Nearly 400 people took part in the study. Some received Darzalex Faspro with VRd, while others received VRd alone. Researchers followed patients to see how well the treatments worked and how long the disease stayed under control. More people who received Darzalex Faspro with VRd reached MRD negativity, meaning doctors could not find remaining myeloma cells using very sensitive testing. These patients also went longer without their disease getting worse.

Why this matters:

Many people diagnosed with multiple myeloma are older or have other health conditions that make a stem cell transplant unsafe. This approval gives doctors a new option at the very start of treatment for these patients, with deeper responses and longer disease control.

The International Myeloma Foundation is grateful to Dr. Saad Usmani, who leads the CEPHEUS study and serves on the IMF Scientific Advisory Board and the International Myeloma Working Group. His leadership helps keep patient needs at the center of myeloma research and care.

Learn more about this development at:
https://mmsm.link/4rCL639

At the International Myeloma Foundation, we are committed to helping people living with myeloma and their families understand new treatment options and what they may mean for care decisions. Call us. We’re here for you. The IMF’s InfoLine is available to answer your myeloma-related questions and concerns. Call 1-818-487-7455 or email infoline@myeloma.org

Meet Heather Cooper Ortner,IMF President & CEO, as she answers questions from myeloma patients, care partners, and advoc...
01/27/2026

Meet Heather Cooper Ortner,IMF President & CEO, as she answers questions from myeloma patients, care partners, and advocates; covering clinical trials, access to care, support groups, and hope for the future. Watch now: https://mmsm.link/3NxXvXk

Have myeloma questions? Myelo has answers.Visit myeloma.org to ask your myeloma-related questions 24/7.Prefer to speak w...
01/26/2026

Have myeloma questions? Myelo has answers.
Visit myeloma.org to ask your myeloma-related questions 24/7.

Prefer to speak with someone directly? Our Information Coordinators are here to help.
Call 1-818-487-7455 or email infoline@myeloma.org to get started.

01/25/2026

Want to speed up myeloma progress?
iStopMM leader Dr. Sigurdur Kristinsson asked IMF President & CEO Heather Cooper Ortner what matters most. She says it starts with people joining in the research.

01/24/2026

Get to know the leader guiding what’s next for the IMF.
Meet President & CEO Heather Cooper Ortner. Heather brings years of patient advocacy leadership experience and a deep commitment to helping people live well with myeloma.
Say hello in the comments! ❤️

Address

4400 Coldwater Canyon Avenue , Suite 300
Studio City, CA
91604

Opening Hours

Monday 8:30am - 4:15pm
Tuesday 9am - 4:15pm
Wednesday 8:30am - 4:15pm
Thursday 8:30am - 4:15pm
Friday 8:30am - 4:15pm

Website

Alerts

Be the first to know and let us send you an email when International Myeloma Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About the IMF

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy.